Content about Placebo

April 8, 2013
Patients taking AstraZeneca RA drug show partial improvement

An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.

March 22, 2013
Novo Nordisk drug produces significant weight loss in study

A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.

October 22, 2012
J&J drug appears more effective in ulcerative colitis patients than placebo, according to study

More patients with an inflammatory disease of the bowels responded to a drug used for autoimmune disorders than those taking a placebo, according to results of a late-stage clinical trial announced Monday.

October 19, 2012
British study: Swiss echinacea extract helps prevent common cold

British researchers have concluded that a Swiss echinacea extract is both safe and effective in helping to prevent symptoms of the common cold, according to a study published in American Botanical Council's peer-reviewed journal HerbalGram.

September 10, 2012
Patients who stop taking insomnia drug continue having sleeping problems, Merck study finds

A study of an experimental drug for insomnia indicated that patients who stop taking it continue having sleeping problems, according to results of a clinical trial announced Monday.

August 23, 2012
AcelRx starts third phase-3 trial of drug for post-operative pain

A drug maker that specializes in pain medications started the third late-stage trial of a drug for treating pain in patients who have undergone certain surgeries.

July 23, 2012
Pfizer pain drug doesn't affect sperm production, study finds

A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.

June 1, 2012
Patients with MS show reduction in symptoms during drug trial

An experimental drug for multiple sclerosis produced a noticeable reduction in symptoms of the disease in a late-stage clinical trial, the drug's developer said Friday.

May 24, 2012
Lilly, BI diabetes drug shows greater A1C reduction in African-American adults than placebo, study shows

A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.

April 4, 2012
Nutramax celebrates 20 years

Nutramax Labs, known for its glucosamine and chondroitin products, on Tuesday celebrated its 20th anniversary, the company announced.

March 15, 2012
Late-stage trial of MS drug shows positive results

A drug under investigation by Teva Pharmaceutical Industries and Active Biotech reduced symptoms and progression of disease in patients with multiple sclerosis, according to results of a late-stage clinical trial.

March 7, 2012
Forest, Pierre Fabre drug 'significantly' reduced depression symptoms

A drug under development by Forest Labs and Pierre Fabre "significantly" reduced symptoms of major depressive disorder, the companies said Wednesday.

March 5, 2012
Study finds Teva allergy drug safe, effective

A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

December 16, 2011
Lyrica produces 'significant' improvement in restless legs syndrome

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

December 7, 2011
Drug shows improvement in symptoms of autism in children

A drug in late-stage clinical trials appears to treat the symptoms of autism, the drug's developer said Wednesday.

November 21, 2011
Factor Nutrition presents study on supplement supporting memory

Factor Nutrition Labs on Monday presented a study supporting supplementation with its FocusFactor product to improve brain function before the Gerontological Society of America.

November 10, 2011
Study: Omega-3s credited with lowering inflammation, anxiety

A recent study gauging the impact of consuming more fish oil showed a marked reduction both in inflammation and in anxiety among a cohort of healthy young people, the Ohio State University Center for Clinical and Translational Science announced Wednesday.

September 16, 2011
BMS, AstraZeneca drug added to insulin reduces blood sugar more than placebo

A diabetes drug made by Bristol-Myers Squibb and AstraZeneca significantly reduced Type 2 diabetes patients' blood-sugar levels, compared with placebo, when added to insulin, according to results of a new study.

August 17, 2011
Savient gout drug shows improvements, according to study

Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

August 10, 2011
Study: Soy supplementation ineffective versus relief of menopausal symptoms

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

June 29, 2011
Adding dapagliflozin to diabetes regimen may help reduce blood sugar, weight among patients

Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.

May 5, 2011
Pfizer: Pristiq reduces hot flashes among postmenopausal women

A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.

March 17, 2011
Late-stage trial to commence for AstraZeneca's opioid-induced constipation treatment

Anglo-Swedish drug maker AstraZeneca has enrolled the first patient in a late-stage clinical trial for a drug to treat constipation related to use of opioid painkillers, the company said.

February 4, 2011
Enbrel helps improve conditions of psoriasis patients, study finds

A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

January 24, 2011
Study: TheraTears Nutrition improves eye health

Advanced Vision Research on Monday announced results from a pilot trial published in the journal Cornea that demonstrated a reduction in dry-eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears Nutrition, an optimized blend of omega-3 oils.

© 2013 Drug Store News. All Rights Reserved.